Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,363,448
+$501,837 QoQ
Shares Held
49,521
+1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#937
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. MRK ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,363,448 | 49,521 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,861,611 | 48,729 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,889,221 | 46,449 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,529,760 | 42,056 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,304,771 | 41,748 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $4,126,805 | 45,976 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $4,694,560 | 47,191 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,368,331 | 56,079 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $6,790,182 | 54,848 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $7,089,409 | 53,728 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $5,856,118 | 53,716 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,532,327 | 53,738 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $5,814,502 | 50,390 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,362,587 | 50,405 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,171,149 | 55,621 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $5,034,919 | 58,464 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $5,436,467 | 59,630 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,568,979 | 67,873 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,297,507 | 95,218 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $7,996,886 | 106,469 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,353,464 | 94,554 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,749,671 | 61,612 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,915,768 | 60,095 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,903,960 | 47,064 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,579,916 | 46,294 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,084,369 | 40,088 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||